OptiNose Competitors and Similar CompaniesClear all
Veloxis Pharmaceuticals's competitors and similar companies include Intersect ENT.
 Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. |  Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. | |
Founding Date | Founding Date 2002 | Founding Date 2003 |
Type | Type Subsidiary | Type Subsidiary |
Tags | ||
Locations | Locations København, DK HQ Cary, US Cary, US | Locations Menlo Park, US HQ |
Employees | Employees 54 | Employees 4337% increase |
Financial | ||
Revenue (est.) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) $106.7m (FY, 2021) |
Cost of goods | Cost of goods kr7.9m (FY, 2018) | Cost of goods $30m (FY, 2021) |
Gross profit | Gross profit kr31.6m (FY, 2018) | Gross profit $76.7m (FY, 2021) |
Net income | Net income (kr5.3m) (FY, 2018) | Net income ($159.6m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 102.9m |
For sources of this data, please see the company profile
View Company Profiles
Intersect ENT
HQ
Menlo Park, US
Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.
View company